Support Pancreatic and Liver Function GLP-1 medications act directly on pancreatic pathways, so supporting the organs involved in glucose regulation is important
As key patents for leading products (such as semaglutide and tirzepatide) approach expiration in various countries, a new wave of companies, ranging from traditional generics manufacturers to complex peptide manufacturers and hybrid developers, is preparing to enter the market
Your transformation starts now
GLP-1 receptor agonists, like semaglutide and tirzepatide, could be a game-changer in reducing cardiovascular disease in this vulnerable group
[27] Until Phase 3 data are available and regulatory review is complete, the full clinical profile of retatrutide remains under investigation, and all findings should be interpreted with appropriate caution
Neighbourhood socioeconomic status and overweight/obesity: a systematic review and meta-analysis of epidemiological studies